BioSpace News Archive

BioIVT, a leading provider of biospecimens and related services, today announced that it is sponsoring the Powering Precision Health Summit (PPHS) 2017.

The company provided a strategy update and announced its consolidated revenues and cash position at September 30, 2017.

Irish based Arran Chemical Company has responded to client demand for provision of fine chemicals, pharmaceutical intermediates and advanced building blocks by implementation of its ADAPT (Arran Deploys Advanced Production Technologies) strategy through a multi-million Euro investment and application of its selectAZyme technology.

MediWound intends to use the net proceeds from this offering to fund r&d activities.

Seasoned executive to lead biometric remote monitoring company’s finance department and accelerate its go-to-market strategy.

Data from this trial was also presented at the conference yesterday.

Pegfilgrastim is a long-acting formulation of filgrastim and Sandoz is seeking approval for use of its biosimilar in the same indication as the reference medicine.

Genentech announced today that new OCREVUS (ocrelizumab) data are being presented at the 7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).

The study is designed to investigate the immune tolerance induction potential of Elocta in patients with hemophilia A who have developed inhibitors which have failed to be resolved with other therapies.

Kyowa Hakko Kirin announces that its MAA for mogamulizumab, for the treatment of cutaneous T-cell lymphoma in adults who have received at least one prior systemic therapy.